Skip to content
10-K

Annual Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-19-001147

← back to feed
Filed
Jun 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Jun 3, 2019 100M sh
Operating Cash Flow FY 2018 · Dec 31, 2017 −$299.74K
Current Liabilities FY 2018 · Dec 31, 2017 $105.43K
Total Liabilities FY 2018 · Dec 31, 2017 $105.43K
Current Assets FY 2018 · Dec 31, 2017 $1.19K
Total Assets FY 2018 · Dec 31, 2017 $1.19K
Sga Expense FY 2018 · Dec 31, 2017 $175.86K
Net Income FY 2018 · Dec 31, 2017 −$175.86K
Operating Income FY 2018 · Dec 31, 2017 −$175.86K
Cash And Equivalents FY 2018 · Dec 31, 2016 $100.93K
Stockholders Equity FY 2018 · Dec 31, 2016 −$128.38K